Ebola Treatment Trial Launches in DR Congo for Bundibugyo Strain
The Reuters segment covers the start of a clinical trial for Ebola virus disease treatments in the Democratic Republic of the Congo during an active outbreak. It highlights ongoing research to identify effective molecules, lists MBP134, remdesivir, and supportive care among options, and notes the study's four-arm design. The broadcast draws on statements from health officials involved in the response and references the trial structure run by DRC’s National Institute for Biomedical Research with international partners including the WHO.
Source: Reuters